Vista Current Coverage

All posts by John Heerdink

Cisco Q3 Earnings Quick Review

Cisco Systems, Inc. (CSCO) is a global technology leader that designs, manufactures, and sells Internet Protocol based networking and other communications technology. Cisco reported its Q3 earnings of $.66/share on May 16, 2018, after the market close. The company met the estimates that called for...

The Home Depot’s Q1 Earnings Report & Review

The Home Depot, Inc. (HD) is the world’s largest home improvement retailer with retail stores all across North America. The Home Depot sells building materials and home improvement products, as well as lawn and garden supplies, and provides installation, home maintenance, and professional service programs....

Breast Cancer Innovator Atossa Genetics Receives Second Positive Interim Safety Review from Independent Safety Committee in Study of Men With Male Breast Enlargement

Seattle based Atossa Genetics Inc. (ATOS), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods to treat breast cancer and other breast conditions, has received a second positive interim safety review on its Phase 1 study of topical Endoxifen in men, which is being...

First Choice Bancorp Receives FDIC Approval of Proposed Merger – Awaits California Department of Business Oversight Ruling

First Choice Bancorp founded in 2005, has quickly become a leading provider of financial services that enable their customers to grow, maintain strength, and achieve their business objectives. They strive to surpass their clients’ expectations through their efficiency and professionalism and are committed to being...

Cisco’s Acquisition of AI Technology Provider Accomany is Complete

Cisco Systems, Inc. (CSCO) is a global technology leader that designs, manufactures, and sells Internet Protocol based networking and other communications technology. Cisco announced its $270M completion of the obtainment of the privately held Accompany on May 10, 2018. The Los Altos, California-based company provides...

Seattle’s Atossa Genetics Publishes Q1 2018 Financial Results & Company Update – Schedules Call For May 16 4:30pm EDT

Seattle based Atossa Genetics Inc. (ATOS), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods to treat breast cancer and other breast conditions, publishes its Q1 ended March 31, 2018, financial results and provided an update on recent company developments. Atossa’s highlighted the following...